Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
ENEnovis Corporation logo

Enovis Corporation (ENOV)

New York Stock Exchange · Currency in USD
$21.08 ▼ -0.51 (-2.36%)
At close: Oct 23, 4:00 PM ET. Market closed.
$21.08 ▲ +0.00 (+0.00%)
After hours: Oct 23, 5:26 PM ET

Summary

Previous Close
$21.59
Open
$21.39
Day's Range
$20.86 – $21.70
52 Week Range
$16.70 – $34.28
Volume
952,832
Avg. Volume
1,428,129
Market Cap
$1.22B
Beta (5Y Monthly)
1.48
PE Ratio (TTM)
--
EPS (TTM)
-$19.13
Earnings Date
Nov 5, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$36.33

Profile: Enovis Corporation

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
7,802
CEO
Damien McDonald
Website
enovis.com

Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment.

Earnings

Next report: Thu, Nov 5, 2026
EPS estimate $0.77 · Revenue est. $557.15M
DateEst.Actual
Aug 6, 2026$0.85$0.90Beat
May 7, 2026$0.82$0.89Beat
Feb 26, 2026$0.81$0.95Beat
Nov 6, 2025$0.67$0.75Beat
Aug 7, 2025$0.74$0.79Beat
May 8, 2025$0.74$0.81Beat

Analyst view

Consensus price target
$36.33 ▲ +72.3%
Range $27.00 – $45.00
Rating: Buy
Buy 80% · Hold 20% · Sell 0%

Get free alerts on ENOV and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.